Management of Inflammatory Bowel Disease

Freidman S. General principles of medical therapy of inflammatory bowel disease. Gastroenterology Clin N Am 2004;33:191-208.

Vasiliaukas E. Pediatric inflammatory bowel disease. Curr Treat Options Gastroenterol. 2000;3:403-424.

Travassos J. Infliximab: use in inflammatory bowel disease . Curr Treat Options Gastroenterol. 2005;8:187-196.

Sachar DB Ten common errors in management of inflammatory bowel disease. Inflamm Bowel Dis. 2003; 9:205-209.

Schroeder KW , Tremaine WJ , Ilstrup DM Coated oral 5 amino salicylic acid therapy for mildly to moderately active ulcerative colitis. N Engl J Med. 1987;317: 1625-1629.

Stein RB , Hanauer B. Comparative tolerability of treatments for inflammatory bowel disease. Drug Saf. 2000; 23:429-448.

Kane SV , Schoenfeld P. , Sandborn WJ , Tremaine W. , Hofer T. , Feagan BG Systematic review: the effectiveness of budesonide therapy for Crohn's disease . Aliment Pharmacol Ther. 2002;16:1509-1517.

Kornbluth A Marion JF , Sakomon P. , Janowitz HD How effective are current medical therapy for severe ulcerative and Crohn's colitis? An analytical review of selected trials. J Clin Gastroenterol. 1995;20:280-284.

van Dullemen HM , van Deventer SJ , Hommes DW , Bijl HA , Jansen J. , Tytgat GN , et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology. 1995;109: 129-135.

Hannauer SB , Feagan BG , Lichtenstein GR , Mayer LF , Schreiber S. , et al. ACCENT 1 Study Group. Maintenance Infliximab for Crohn's disease: The ACCENT 1 randomized trial. Lancet. 2002 ;359:1541-1549.

Brzezinski A. , Rankin GB , Seidner DL , Lashner BA 5-aminosalicylic acid in inflammatory bowel disease: old and new preparations. Cleve Clin J Med. 1995;62:317-323.

Jani N. , Reguiero MD Medical therapy for ulcerative colitis. Gastroenterol Clin North Am. 2002;31: 147-166.

Banerjee S. , Peppercorn MA Inflammatory bowel disease: medical therapy of specific clinical presentations. Gastroenterology Clin North Am. 2002;31: 185-202.